Latest Board Transitions News

Kingfish Limited posted a $13.6 million net loss for the year ended 31 March 2026, with portfolio returns lagging the benchmark amid geopolitical tensions and AI sector uncertainty.

Forrestania Resources has launched a recommended off-market takeover bid for Zenith Minerals, valuing Zenith at about A$93.5 million with a 46.7% premium. The deal aims to create a larger, diversified Western Australian gold explorer and developer.

Findi Limited has transitioned Stephen Benton to Non-Executive Chairman while Nicholas Smedley refocuses on the Indian business and TSI IPO plans. A strategic review aims to sharpen capital allocation and progress the Payments Bank licence.

Elanor Investors Group appoints David McNamara as CEO, signaling a leadership shift following a balance sheet recapitalisation and strategic reset. The Board also sees key transitions with Tony Fehon moving to a non-executive role and Su Kiat Lim stepping down.

Urbanise.com Limited appoints Darc Rasmussen as Executive Chairman, unveils an AI Assistant for strata managers, and converts two legacy system customers with new contracts worth $700k over three years.

Zenith Minerals has reported a significant milestone with a maiden 675,000-ounce JORC Inferred Mineral Resource at its Consolidated Dulcie Gold Project, alongside deep drilling success at Red Mountain that extends mineralisation beyond 700 metres.

GreenTech Metals has consolidated a dominant West Pilbara position by acquiring 70% of the Munni Munni PGE-Cu-Ni Project and completed a cost-saving Phase 1 drilling and historic core resampling program. Early data hints at significant resource expansion ahead of a JORC 2012 upgrade.

Energy Action Limited posted a milestone quarter ending March 2026, delivering positive operating cash flow for the first time in FY26 alongside strong revenue gains and a notable $0.5 million debt repayment. Governance changes add a layer of uncertainty ahead of a scheduled general meeting.

Alligator Energy has appointed Dr Andrea Marsland-Smith as Managing Director in addition to her CEO role, while preparing for the retirement of veteran Non-Executive Director Peter McIntyre following a key project milestone.

Island Pharmaceuticals reports a 213.8% increase in half-year loss to $4.81 million, driven by strategic acquisition and clinical development investments. The company advances its antiviral portfolio with Galidesivir and ISLA-101, supported by strong US regulatory engagement and a $9 million capital raise.

Woodside Energy Group Ltd reported record production and a net profit after tax of $2.7 billion in 2025, advancing key LNG and ammonia projects while achieving its 15% emissions reduction target.

ChemX Materials Limited has completed its Deed of Company Arrangement and appointed a new board, yet remains suspended from ASX trading while relying on director-related funding. The company is focused on stabilisation and exploring future opportunities.